Circadian rhythm of luteinizing hormone secretion in the ovariectomized rat implanted with oestradiol

Chronic estradiol exposure suppresses luteinizing hormone surge without affecting kisspeptin neurons and estrogen receptor alpha in anteroventral periventricular nucleus†

Mammalian ovulation is induced by a luteinizing hormone surge, which is triggered by elevated plasma estrogen levels; however, chronic exposure to high levels of estradiol is known to inhibit luteinizing hormone secretion. In the present study, we hypothesized that the inhibition of the luteinizing hormone surge by chronic estradiol exposure is due to the downregulation of the estrogen receptor alpha in kisspeptin neurons at hypothalamic anteroventral periventricular nucleus, which is known as the gonadotropin-releasing hormone/luteinizing hormone surge generator. Animals exposed to estradiol for 2 days showed an luteinizing hormone surge, whereas those exposed for 14 days showed a significant suppression of luteinizing hormone. Chronic estradiol exposure did not affect the number of kisspeptin neurons and the percentage of kisspeptin neurons with estrogen receptor alpha or c-Fos in anteroventral periventricular nucleus, but it did affect the number of kisspeptin neurons in arcuate nucleus. Furthermore, chronic estradiol exposure did not affect gonadotropin-releasing hormone neurons. In the pituitary, 14-day estradiol exposure significantly reduced the expression of Lhb mRNA and LHβ-immunoreactive areas. Gonadotropin-releasing hormone-induced luteinizing hormone release was also reduced significantly by 14-day estradiol exposure. We revealed that the suppression of an luteinizing hormone surge by chronic estradiol exposure was induced in association with the significant reduction in kisspeptin neurons in arcuate nucleus, luteinizing hormone expression in the pituitary, and pituitary responsiveness to gonadotropin-releasing hormone, and this was not caused by changes in the estrogen receptor alpha-expressing kisspeptin neurons in anteroventral periventricular nucleus and gonadotropin-releasing hormone neurons, which are responsible for estradiol positive feedback.

Kobayashi Award 2019: The neuroendocrine regulation of the mammalian reproduction

Mammalian reproductive function is a complex system of many players orchestrated by the hypothalamus-pituitary-gonadal (HPG) axis. The hypothalamic gonadotropin-releasing hormone (GnRH) and the consequent pituitary gonadotropin release show two modes of secretory patterns, namely the surge and pulse modes. The surge mode is triggered by the positive feedback action of estrogen secreted from the mature ovarian follicle to induce ovulation in females of most mammalian species. The pulse mode of GnRH release is required for stimulating tonic gonadotropin secretion to drive folliculogenesis, spermatogenesis and steroidogenesis and is negatively fine-tuned by the sex steroids. Accumulating evidence suggests that hypothalamic kisspeptin neurons are the master regulator for animal reproduction to govern the HPG axis. Specifically, kisspeptin neurons located in the anterior hypothalamus, such as the anteroventral periventricular nucleus (AVPV) in rodents and preoptic nucleus (POA) in ruminants, primates and others, and the neurons located in the arcuate nucleus (ARC) in posterior hypothalamus in most mammals are considered to play a key role in generating the surge and pulse modes of GnRH release, respectively. The present article focuses on the role of AVPV (or POA) kisspeptin neurons as a center for GnRH surge generation and of the ARC kisspeptin neurons as a center for GnRH pulse generation to mediate estrogen positive and negative feedback mechanisms, respectively, and discusses how the estrogen epigenetically regulates kisspeptin gene expression in these two populations of neurons. This article also provides the mechanism how malnutrition and lactation suppress GnRH/gonadotropin pulses through an inhibition of the ARC kisspeptin neurons. Further, the article discusses the programming effect of estrogen on kisspeptin neurons in the developmental brain to uncover the mechanism underlying the sex difference in GnRH/gonadotropin release as well as an irreversible infertility induced by supra-physiological estrogen exposure in rodent models.

Phenobarbital blockade of the preovulatory luteinizing hormone surge: association with phase-advanced circadian clock and altered suprachiasmatic nucleus Period1 gene expression

The suprachiasmatic nucleus (SCN) controls the timing of the preovulatory luteinizing hormone (LH) surge in laboratory rodents. Barbiturate administration during a critical period on proestrus delays the surge and prolongs the estrous cycle 1 day. Because a nonphotic timing signal (zeitgeber) during the critical period that phase advances activity rhythms can also induce the latter effect, we hypothesized that barbiturates delay the LH surge by phase-advancing its circadian timing signal beyond the critical period. In experiment 1, locomotor rhythms and estrous cycles were monitored in hamsters for 2-3 wk preinjection and postinjection of vehicle or phenobarbital and after transfer to darkness at zeitgeber time (ZT) 6 on proestrus. Phenobarbital delayed estrous cycles in five of seven hamsters, which exhibited phase shifts that averaged twofold greater than those exhibited by vehicle controls or phenobarbital-injected hamsters with normal cycles. Experiment 2 used a similar protocol, but injections were at ZT 5, and blood samples for LH determination were collected from 1200 to 1800 on proestrus and the next day via jugular cannulae inserted the day before proestrus. Phenobarbital delayed the LH surge 1 day in all six hamsters, but it occurred at an earlier circadian time, supporting the above hypothesis. Experiment 3 investigated whether phenobarbital, like other nonphotic zeitgebers, suppresses SCN Period1 and Period2 transcription. Two hours postinjection, phenobarbital decreased SCN expression of only Period1 mRNA, as determined by in situ hybridization. These results suggest that phenobarbital advances the SCN pacemaker, governing activity rhythms and hormone release in part by decreasing its Period1 gene expression.

Loss of luteinizing hormone surges induced by chronic estradiol is associated with decreased activation of gonadotropin-releasing hormone neurons

Chronic exposure of young ovariectomized rats to elevated circulating estradiol causes loss of steroid-induced LH surges. Such LH surges are associated with cFos-induced activation of GnRH neurons; therefore, we hypothesized that chronic estradiol treatment abolishes LH surges by decreasing activation of GnRH neurons. Regularly cycling rats were ovariectomized and immediately received an estradiol implant or remained untreated. Three days or 2 or 4 wk later, the estradiol-treated rats received vehicle or progesterone at 1200 h, and 7 hourly blood samples were collected for RIA of LH. Thereafter, all rats were perfused, and the brains were examined for immunocytochemical localization of cFos and GnRH. The GnRH neurons from untreated ovariectomized rats rarely expressed cFos. As reported, LH surges induced by 3 days of estradiol treatment were associated with a 30% increase in cFos-containing GnRH neurons, and progesterone enhanced both the amplitude of LH surges and the proportion of cFos-immunopositive GnRH neurons. As hypothesized, the abolition of LH surges caused by 2 or more weeks of estradiol was paralleled by a reduction in the percentage of cFos-containing GnRH neurons, and this effect was delayed by progesterone. These results suggest that chronic estradiol abolishes steroid-induced LH surges in part by inactivating GnRH neurons.

Chronic elevation of estradiol in young ovariectomized rats causes aging-like loss of steroid-induced luteinizing hormone surges

This study was designed to test the hypothesis that the loss of LH surges in response to the stimulatory actions of estradiol and progesterone in middle-aged, persistent-estrous (PE) rats may be caused by chronic elevations in circulating estradiol. Five groups of regularly cycling young rats received an s.c. estradiol implant immediately after ovariectomy (Day 0). For determination of LH surges, blood samples were collected hourly between 1200-1900 h from each of the five groups at one of the following times: 3 days, or 1, 2, 4, or 8 wk later. On the next day, either progesterone (0.5 mg/100 g BW) or corn oil was injected s.c. at 1200 h, and samples were obtained as before. Incidence and amplitude of estradiol-induced LH surges decreased during the first 2 wk of estradiol treatment, after which no surges occurred. Progesterone enhanced the incidence and amplitude of estradiol-induced LH surges thus delaying their disappearance. These results support our hypothesis and demonstrate that the stimulatory actions of estradiol and progesterone on the LH surge sequentially diminish with time after exposure to estradiol in young rats. Thus, young rats chronically treated with estradiol may be a useful model for studying the mechanisms whereby LH surges are abolished in middle age during the hyperestrogenic state of PE.

Regulation by estradiol of GABAA and GABAB binding sites in the diencephalon of the rat: an autoradiographic study

Using in vitro quantitative autoradiography we studied the in vivo effects of estradiol on GABAA and GABAB receptors in the rat brain. In all the areas studied (suprachiasmatic nucleus, medial preoptic area, striatum, frontal cortex), estradiol failed to significantly affect the GABAA receptor density. Chronic treatment with estradiol led however in the suprachiasmatic nucleus and the striatum to a decrease in the density of GABAB receptors. GABAB receptor regulation by estradiol was found to be area-specific within the hypothalamus since it was not observed in the medial preoptic area. The down regulation of GABAB receptors in the suprachiasmatic nucleus induced by estradiol treatment might thus explain the inhibitory effect of the steroid on the GABA control of serotonin metabolism we recently reported.

Induction of gonadotropin surge by steroid hormone implantation in ovariectomized and sexually regressed female goldfish

Involvement of steroid hormones in the occurrence of the ovulatory gonadotropin (GtH) surge was studied in goldfish. Ovariectomized female goldfish were implanted with an empty Silastic capsule or a capsule containing testosterone or estradiol, and kept below 12 degrees for 3 months (Experiment 1). Some of the steroid implanted fish showed a GtH surge which was quite similar to the normal ovulatory GtH surge in response to a water temperature rise from 12 to 20 degrees, whereas no surge was observed in fish with empty capsules. When sexually regressed female goldfish were implanted with the capsules containing testosterone or estradiol and kept at 12 degrees for 6 weeks out of spawning season, the GtH surge was also observed in these fish after the water temperature rise to 20 degrees (Experiment 2). The GtH surge was observed in a larger number of testosterone-implanted fish than in the estradiol-treated fish in both experiments. These results strongly suggest that the high plasma level of testosterone observed before ovulation is an important physiological requisite for the occurrence of the ovulatory GtH surge in goldfish.

Hormone changes during the ovulatory cycle in goldfish

Hormone profiles during the ovulatory cycle were studied in goldfish. Blood samples were taken from female goldfish every 4 days between 1400 and 1700 hr during the course of repeated ovulations for a duration of 3 months, and plasma hormone levels of 3 days before and after ovulation were compared. Plasma gonadotropin (GtH) levels did not show significant changes except a surge for ovulation, but tended to show higher levels before the surge than those after the surge. Plasma testosterone before ovulation showed significantly higher levels compared with those after ovulation. Plasma estradiol-17 beta (E2) levels remained low for 3 days prior to ovulation. Postovulation E2 levels that were significantly higher than the preovulation levels were kept elevated and declined on the third day after ovulation. These results indicate that E2 is mainly produced in the first part of the ovulatory cycle and testosterone in the latter part followed by the GtH surge and ovulation at the end of the cycle. This shift in steroid pattern from E2 to testosterone seems to be similar to those observed in salmonid fishes except for the time scale. The synchrony of ovulation in goldfish is also discussed in relation to physiological and external factors which influence the occurrence of ovulation.

Effect of an inhibitor of aromatization, 1,4,6 androstatriene-3,17-dione (ATD) on LH release and steroid binding in hypothalamus of adult female rats

Prevention of testosterone aromatization in the female rat pups by perinatal treatment with 1,4,6 androstatriene-3,17-dione (ATD) induces an important defeminization as shown by a reduction of fluctuations of LH release after castration and estradiol implantation. The fact that, under our in vitro experimental conditions, ATD is able to displace testosterone binding in the hypothalamus whereas estradiol does not, confirms the hypothesis that ATD acts on aromatase. The most attractive explanation for the defeminization effect of ATD is then an estrogen-like action of ATD.

The role of endogenous serotonin in phasic LH release

Injection of the serotonin inhibitor, fluoxetine (75 micrograms) into the hypothalamus (IC) of ovariectomized (Ovx.) rats treated with 17beta-Estradiol (E2) and parachlorophenylalanine (PCPA 150 mg/kg) significantly increased the luteinizing hormone (LH) in these rats 24 hours later when PCPA had suppressed the LH surge in a parallel group of sham rats. There was a temporal delay in these changes of LH (and by implication serotonin metabolism), since there was no significant effect on the blocked LH surge within two hours of the injection. Since steroids play a major role in gonadotropin secretion and PCPA has been shown to depress LH release, it is interesting that E2 increased the rate of H-3 serotonin (1 X 10(-7) M) uptake in hypothalamic synaptosomes. This suggests a mechanism to increase the removal of synaptic serotonin and the low concentrations of serotonin used in these experiments suggest that uptake occurred in the high affinity serotonin uptake pump and can be influenced by ovarian steroids. This is in contrast to the saturation uptake of serotonin which was unaffected by steroids.

Hyperprolactinemia and estrogen-induced rhythms in LH and prolactin release in the ovariectomized rat

Short-term (9 days) hyperprolactinemia induced by pituitary grafts reduced basal plasma LH levels in ovariectomized rats whereas long-term (31 days) grafts increased basal LH levels. Although long-term grafts inhibited estradiol-induced prolactin surges, hyperprolactinemia had no effect on the LH surge. It is concluded that the estrogen-treated ovariectomized rat is not suitable for studying the effects of hyperprolactinemia on LH release.

Impact of age-related changes in serotonin and norepinephrine metabolism on reproductive function in female rats: an analytical review

This review attempts to reconcile changes in brain NE and 5HT metabolism with the effects of aging, drug treatment and altered photoperiods on phasic and tonic release of LH in the female. A hypothesis is presented in which 5HT has "indirect" and "direct" effects on LH surges. The "indirect" ones facilitate LH surges via a generalized effect of 5HT on temporal organization within multiple neuroendocrine axes. Thus, 5HT promotes circadian rhythmicity in many systems due to its participation in the biological "clock" mechanism of the hypothalamus. The "direct" ones that are specific to the LH releasing mechanism also occur for 5HT (inhibitory) as well as for NE (facilitory) due to the interaction of these transmitters with LH-RH secreting neurons. It is proposed that metabolic changes during aging that favor 5HT at the expense of NE obliterate the facilitatory effects of both amines while enhancing the inhibitory component of 5HT's influence on LH secretion.

Diurnal variations in estradiol binding site concentrations in the hypothalamus, pituitary and uterus of prepuberal rats

Available cytosolic estradiol binding sites (EBS) were estimated at 6 h intervals over a 24 h period in individual extracts of uteri, pituitaries and hypothalami from intact, ovariectomized or hypophysectomized 28-day old rats, maintained from birth in a 12 h light-12 h dark photoperiod. Plasma estrogen levels were also recorded, in intact rats, they displayed a 20% rise during daytime. In the uterus and pituitary of ovariectomized rats EBS concentrations exceeded by one third those of intact controls. In intact animals, significant diurnal variations in EBS were observed in both these tissues, with increased daytime levels. These variations appeared to depend on the amount of estrogen in the plasma, as they were not observed in spayed rats. No diurnal variations in EBS were apparent in the hypothalamus of intact animals, but they did occur in ovariectomized rats, and even more significantly in hypophysectomized rats, although the latter had lower EBS concentrations than spayed animals. These variations were presumed to result from the interference of pituitary-controlled hormones other than estrogens in the regulation of EBS levels.

Circadian surges of LH in the ovariectomised rat occur coincident with enhanced pituitary responsiveness to GnRH

Experiments are described in which we have investigated the responsiveness to GnRH of pituitary glands obtained from ovariectomised rats in which LH surges were induced by steroid priming (a) by estrogen implants and (b) by estrogen-progesterone injections. These treatments generate LH surges late in the light phase. Stimulation with GnRH in vitro revealed a large increase in responsiveness coincident with the surge of LH. We suggest that this effect is mediated through a self-priming effect of GnRH and that this in vitro technique may be used to detect hypothalamic release of GnRH.

Evidence that a 'critical period' is involved in early estrogen-induced LH- and FSH-release during the estrous cycle in the rat

LH- and FSH-release, which occurred in the afternoon of diestrus 1 following estradiol benzoate administration in the morning of estrus, was completely prevented by pentobarbital, when injected on diestrus 1 at 13.30 h.

Interaction of the anti-estrogen CI-628 and estradiol on plasma LH and hypothalamic LH-RH in the female rat

The effects of the anti-estrogen Ci-628 have been tested on both plasma LH and hypothalamic LH-RH content in ovariectomized or ovariectomized, estradiol (E2)-implanted rats, in order to correlate those parameters with the [3H]E2 retention in the hypothalamus and the pituitary. Incresing doses of CI-628 induced a dose-dependent inhibition of [3H]E2 retention in both cytosolic and nuclear fractions of the pituitary. In contrast, hypothalamic retention of [3H]E2 is only inhibited significantly with higher doses of CI-628 (2.4 and 24 mg/kg). In ovariectomized rats, only a high dose of CI-628 (24 mg/kg) is able to decrease elevated LH levels observed following castration. In the presence of E2, CI-628 has both estrogenic and anti-estrogenic properties on LH secretion. CI-628 acts at the pituitary level to decrease the tissue sensitivity to LH-RH, but has no effect on mediobasal hypothalamic (MBH) LH-RH content.